Breaking News

Home / Business News / Biocartis partners with AstraZeneca on lung cancer diagnostics

Biocartis partners with AstraZeneca on lung cancer diagnostics

November 29, 2018
Belgian molecular diagnostics company Biocartis Group said on Thursday it had entered into an agreement with British drugmaker AstraZeneca to obtain faster lung cancer molecular diagnostic biomarker results in Europe.


from Reuters: Money News https://ift.tt/2r9UWNH

No comments

Subscribe to: Post Comments ( Atom )